USNA (Usana Health Sciences) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

USNA Usana Health Sciences Inc USNA
66 GF Score
Price $22.12
GF Value $41.43
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Usana Health Sciences Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Usana Health Sciences is: High Risk: Good fundamentals, beware of shrinking business.

Usana Health Sciences  (NYSE:USNA) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Usana Health Sciences Risk Assessment Related Terms

USNA vs NATR, ENHA, BYND: Risk Assessment Comparison

For the Packaged Foods subindustry, Usana Health Sciences's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Usana Health Sciences Risk Assessment vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Usana Health Sciences's Risk Assessment falls into.


USNA
66GF Score
Usana Health Sciences Inc USNA
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Usana Health Sciences (USNA) Overvalued in 2026?

Based on GuruFocus' analysis, Usana Health Sciences stock appears to be undervalued. The current stock price of $22.12 is trading 46.6% below its estimated GF Value™ of $41.43. GuruFocus considers Usana Health Sciences to be Possible Value Trap.

Key valuation signals for USNA:

  • Risk Assessment:
  • GF Value™: $41.43 vs. price of $22.12 (46.6% below fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the USNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Usana Health Sciences Business Description

Other Exchanges USJ:Germany
Address 3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
66GF Score

Get the complete analysis for USNA

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.12
Price
$41.43
GF Value